Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bacteriostatic normal saline is a sterile, nonpyrogenic, isotonic solution of 0.9% sodium chloride in water for injection, supplemented with an antimicrobial preservative, typically 0.9% (9 mg/mL) benzyl alcohol. It is primarily utilized as a sterile vehicle or diluent for the reconstitution and dilution of compatible drugs intended for parenteral administration. The presence of the bacteriostatic agent allows for multiple entries into the vial, facilitating the withdrawal of multiple doses from a single container. However, its use is strictly contraindicated in neonates due to the risk of "gasping syndrome" associated with benzyl alcohol toxicity, and it must not be used for epidural or intrathecal anesthesia procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bacteriostatic sodium chloride 0.9% injection.